SCOTUS backs generic firm Hikma in skinny label dispute
SCOTUS has delivered its ruling in a closely watched 'skinny label' lawsuit between Amarin and Hikma, which could have far-reaching implications.
Discover a new era of healthcare panel engagement: Grounded ...
A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
Why pharma needs honest patient dialogue
Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience.
From Alzheimer’s disease research to the real-world setting:...
In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.
Towards a healthier world: Momentum in UK health system tran...
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Lee-Ann Farrell, Head of National Programmes at Johnson & Johnson.
What HCPs Say Pharma Gets Wrong About Survey Research
Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.
Inizio Launches Intelligent Congress to Turn Event Investmen...
Inizio, the leading global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals